Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-28

Clinical Trial Update: Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of tolvaptan in cirrhotic patients with hyponatremia, with the trial status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tolvaptan (tolvaptan)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Liver Cirrhosis, Hyponatremia | Status: COMPLETED